{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:28Z","timestamp":1761489868938,"version":"3.37.3"},"reference-count":45,"publisher":"American Chemical Society (ACS)","issue":"3","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1043225","APP104434"],"award-info":[{"award-number":["APP1043225","APP104434"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP120102778"],"award-info":[{"award-number":["DP120102778"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2016,3,7]]},"DOI":"10.1021\/acs.molpharmaceut.5b00833","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T16:21:21Z","timestamp":1453738881000},"page":"979-989","source":"Crossref","is-referenced-by-count":20,"title":["In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy"],"prefix":"10.1021","volume":"13","author":[{"given":"T.","family":"Parumasivam","sequence":"first","affiliation":[{"name":"Advanced\rDrug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G. Y.","family":"Chan","sequence":"additional","affiliation":[{"name":"Advanced\rDrug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales 2006, Australia"},{"name":"JHL Biotech, Incorporated, Hsinchu 300, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pang","sequence":"additional","affiliation":[{"name":"Tuberculosis\rResearch Program, Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Quan","sequence":"additional","affiliation":[{"name":"Infectious\rDiseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Triccas","sequence":"additional","affiliation":[{"name":"Infectious\rDiseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. J.","family":"Britton","sequence":"additional","affiliation":[{"name":"Infectious\rDiseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia"},{"name":"Tuberculosis\rResearch Program, Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Advanced\rDrug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"ref1\/cit1","unstructured":"World Health Organization Global Tuberculosis Report 2014.http:\/\/apps.who.int\/iris\/bitstream\/10665\/137094\/1\/9789241564809_eng.pdf(accessed March 15, 2015)."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.677"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1586\/ers.09.6"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70328-1"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.136121"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00550-09"},{"key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/82_2012_300","volume-title":"Pathogenesis of Mycobacterium tuberculosis and its interaction with the host organism","volume":"374","author":"Szumowski J.","year":"2013"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2011.08.009"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.2.322"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.022"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu095"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.10.002"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01577-08"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.3390\/ph5091021"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.05.022"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0650OC"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01462-13"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034538"},{"journal-title":"Verapamil (Calan, Verelan, Verelan PM [Discontinued: Isoptin, Isoptin SR, Covera-HS])","year":"2015","author":"Ogbru O.","key":"ref19\/cit19"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01570-07"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1924OC"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240407"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609969"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00669.x"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.94.5.954"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.4"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198325020-00002"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1086\/508278"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.11.009"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040344"},{"key":"ref31\/cit31","unstructured":"Verapamil (Oral Route);Mayo Clinic:Rochester, MN, 2015; http:\/\/www.mayoclinic.org\/drugs-supplements\/verapamil-oral-route\/description\/drg-20071728."},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23911"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.08.007"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1086\/380413"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-008-9175-0"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2008.05.009"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-004-9020-4"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20426"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/mp500586p"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.11.002"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9789-0"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9957-4"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02346-12"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1245-7"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9537-8"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5b00833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T21:11:02Z","timestamp":1681765862000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5b00833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3,7]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5b00833"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00833","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"type":"print","value":"1543-8384"},{"type":"electronic","value":"1543-8392"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}